Table 4.
Association between glycaemic status at baseline and risk of subsequent multimorbidity cluster of cardiovascular disease and cancer in female participants
Variable | Hazard ratios | 95% confidence interval | P value |
---|---|---|---|
Age (years) | 1.04 | 0.99–1.10 | 0.087 |
Smoking (yes = 1) | 0.44 | 0.10–1.86 | 0.26 |
Obesity status (yes = 1) | 1.56 | 0.74–3.28 | 0.24 |
Hypertension status (yes = 1) | 1.40 | 0.67–2.94 | 0.36 |
Hypoglycaemic drugs (yes = 1) | 0.66 | 0.27–1.64 | 0.37 |
Lipid-lowering drugs (yes = 1) | 1.45 | 0.59–3.6 | 0.41 |
Antihypertensive drugs (yes = 1) | 0.92 | 0.38–2.24 | 0.85 |
Glucose status at baseline | |||
Normal glucose tolerance | Reference | ||
Impaired glucose tolerance | 2.52 | 0.82–7.75 | 0.11 |
Newly diagnosed type 2 diabetes | 3.95 | 1.29–12.07 | 0.016 |